Pharma Industry News: December 2006

December 3	Pfizer Stops All Torcetrapib Clinical Trials in Interest of Patient
December 4	King Pharmaceuticals Reports FDA Approval of New Skelaxin Label
December 5	Alimera Sciences Receives FDA Approval to Market Alaway OTC for Up To 12 Hours of Eye Itch Relief
December 5	FDA Warns Five Firms To Stop Compounding Topical Anesthetic Creams
December 7	Eli Lilly and Company Submits NDA for Evista for Reduction of Invasive
December 7	Eli Lilly and Company Submits New Drug Application for Evista for Reduction of Invasive Breast Cancer Risk in Postmenopausal Women
December 8	FDA Approves Velcade (Bortezomib) for Injection for Aggressive Form of Non-Hodgkin’s Lymphoma
December 11	FDA Advances Effort Against Marketed Unapproved Drugs
December 11	FDA Proposes Rules Overhaul to Expand Availability of Experimental Drugs
December 13	FDA Accepts New Drug Application for Sanctura XR Submitted by Indevus
December 13	Reliant Pharmaceuticals Submits New Data to FDA Supporting Use of Omacor With a Statin
December 13	Access Pharmaceuticals Receives MuGard Marketing Clearance From the FDA
December 14	FDA Approves First Generic Bupropion Hydrochloride Extended-Release Tablets
December 15	FDA Revises Labeling for Trasylol
December 15	FDA Approves Drug to Treat Cyanide Poisoning
December 15	Celebrex Approved to Treat Juvenile Rheumatoid Arthritis
December 18	FDA Warns of Safety Concern Regarding Rituxan in New Patient Population
December 18	FDA Approves Foradil Certihaler
December 18	BioSante Pharmaceuticals Receives FDA Approval of Elestrin
December 19	FDA Proposes Labeling Changes to Over-the-Counter Pain Relievers
December 20	FDA Approves Invega, a New Drug for Schizophrenia
December 20	FDA Approves Colazal for Children and Teens With Mildly to Moderately Active Ulcerative Colitis
December 21	FDA Approves New Indication for Invanz
December 22	FDA Approves Byetta (exenatide) Injection for Expanded Combination Use
December 22	Exforge Receives US Regulatory Approval as for Patients with High Blood Pressure
December 26	Osteoporosis Drug Gives Lasting Protection
December 26	HRT Debate Continues
December 26	HRT Debate Continues
December 27	FDA Approves First Generic Ondansetron Tablets, Orally Disintegrating Tablets and Oral Solution
December 27	Medicare's Prescription Drug Plan Enrollment Deadline Looms
December 28	Breast Cancer Treatment Drug Tykerb Slows Tumor Growth

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals